Eli Lilly has selected a leading USA-approved GMP provider to manufacture its groundbreaking medications, Retatrutide and Tirzepatide. This strategic decision demonstrates Lilly's commitment to superiority in manufacturing and ensures patients with access to safe and effective treatments. The chosen partner possesses a proven track record of meetin